| Financial Year |
March 31 2023 |
| Monetary Funds |
93,007,540.49 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
65,251,577.57 |
| Advances to Suppliers |
15,106,599.30 |
| Other Receivables |
40,461,183.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
860,199,805.87 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
16,993,406.23 |
| Other Current Assets |
9,228,191.01 |
| Total Current Assets |
1,103,368,335.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
63,166,733.33 |
| Long-term Equity Investment |
-- |
| Investment Properties |
112,442,375.10 |
| Fixed Assetes |
543,969,226.90 |
| Under-construction Projects |
829,294,865.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
307,849,552.79 |
| R&D expenses |
37,371,088.52 |
| Goodwill |
786,271,795.21 |
| Long-Term Deferred and Prepaid Expenses |
39,163,611.42 |
| Deferred Income Tax Assets |
2,848,447.60 |
| Other Non-Current Assets |
10,698,491.39 |
| Sub-Total of Non-Current Assets |
2,779,671,343.30 |
| Total Assets |
3,883,039,678.80 |
| Short-Term Loans |
433,148,241.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,561,899.00 |
| Accounts Payable |
267,319,713.73 |
| Accounts Received In Advance |
10,024,860.64 |
| Employee Compensation Payable |
28,027,976.81 |
| Taxes Payable |
19,254,428.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
236,778,728.64 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
30,618,994.04 |
| Other Current Liabilities |
362,670.41 |
| Sub-Total of Current Liabilities |
1,047,434,910.42 |
| Long-term Loans |
351,699,902.63 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,594,022.84 |
| Deferred Income Tax Liabilities |
108,075,228.09 |
| Other Non-Current Liabilities |
735,298.01 |
| Sub-Total of Non-Current Liabilities |
502,569,681.61 |
| Total Liabilities |
1,550,004,592.03 |
| Paid-In Capital(Or Share Stock) |
816,900,495.00 |
| Capital Surplus |
754,221,087.46 |
| Surplus Reserve |
1,292,466.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-175,122,240.68 |
| Minority Stockholder's Interest |
934,846,643.50 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,398,188,443.27 |
| Owner's Equity（Stockholder's Equity） |
2,333,035,086.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,883,039,678.80 |
